The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivoswitch trial: Predictive value of PD-L1 in plasma and extracellular vesicles.
 
JAdzia Sonnleithner
No Relationships to Disclose
 
Dirk Himbert
No Relationships to Disclose
 
Philip Zeuschner
Research Funding - Intuitive Surgical
 
Arndt Hartmann
Honoraria - Abbvie; AstraZeneca; BMS; Boehringer Ingelheim; Ipsen; Janssen-Cilag; MSD; Roche
Consulting or Advisory Role - 3DHISTECH; AstraZeneca; Bristol-Myers Squibb; Cepheid; Diaceutics; Illumina; Ipsen; Janssen-Cilag; MSD; NanoString Technologies; Qiagen; Roche
Research Funding - AstraZeneca; BioNTech; Cepheid; Janssen-Cilag; NanoString Technologies; Roche
Expert Testimony - NanoString Technologies
 
Carsten Grüllich
No Relationships to Disclose
 
Philipp Ivanyi
Honoraria - EUSA Pharma; Ipsen; MSD Oncology
Consulting or Advisory Role - Ipsen
 
Manfred Wirth
No Relationships to Disclose
 
Peter Staib
No Relationships to Disclose
 
Martin Schostak
Honoraria - AstraZeneca/MedImmune; Bayer; Janssen Oncology; Merck; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb/Pfizer; EDAP TMS; Ipsen; Janssen Oncology; MSD Oncology; Sanofi
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol Myers Squibb Foundation (Inst); Ipsen (Inst); Janssen Oncology (Inst); MSD Oncology (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bristol-Myers Squibb/Pfizer; EDAP TMS; Merck; MSD Oncology; Pfizer; Sanofi
 
Philip Dargatz
No Relationships to Disclose
 
Lothar Müller
No Relationships to Disclose
 
Viktor Grünwald
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb; Genmab; MSD; Seagen
Honoraria - Advanced Accelerator Applications/Novartis; Apogepha; AstraZeneca; Bristol-Myers Squibb; ClinSol; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; Merck Serono; MSD Oncology; Nanobiotix; Novartis; Ono Pharmaceutical; Pfizer; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Cor2Ed; Debiopharm Group; Eisai; Ipsen; Janssen-Cilag; MSD Oncology; Novartis; Onkowissen; Pfizer
Research Funding - Amgen (Inst); BMS (Inst); Ipsen (Inst); MSD Oncology (Inst); Novartis (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Pfizer
 
Kerstin Junker
Stock and Other Ownership Interests - Bayer Germany
Speakers' Bureau - Ipsen
Research Funding - Ipsen